Stay updated with breaking news from Group Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023
Clinical stage oncology drug company Avacta has announced the acquisition of its Animal Health division by Vimian Group AB (Vimian. Click to read more...
Avacta Group plc , a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that Vimian Group... | March 16, 2022
LONDON (dpa-AFX) - BATM (BVC.L), on Thursday, said it expects to report full year revenue and EBITDA for 2021 slightly ahead of market expectations, reflecting strong growth from ongoing operations
Investegate announcements from Rutherford Health, Half-year Report